Fig. 2From: Effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on cardiovascular events and residual renal function in dialysis patients: a meta-analysis of randomised controlled trialsEffect of ACE-Is or ARBs compared with placebo or other active agents on cardiovascular eventsBack to article page